Calneuron 1 anticorps (AA 51-150)

N° du produit ABIN1386726

Détail du produit anti-Calneuron 1 anticorps

Antigène: Calneuron 1 (CALN1)

Épitope: AA 51-150

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Calneuron 1 est non-conjugé

Application: ELISA, Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunocytochemistry (ICC), Immunohistochemistry (Frozen Sections) (IHC (fro))

Homologie: Human,Mouse,Rat,Dog,Cow,Pig,Horse,Chicken,Rabbit

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human Calneuron 1/CABP8

Isotype: IgG

Information d'application

Indications d'application: ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Date de péremption: 12 months

Détails sur Calneuron 1

Antigène: Calneuron 1 (CALN1)

Autre désignation: Calneuron 1/CABP8 (CALN1 Produits)

Synonymes: anticorps CALN1, anticorps CABP8, anticorps 9630012C17Rik, anticorps Cabp8, anticorps calneuron 1, anticorps CALN1, anticorps caln1, anticorps Caln1

Sujet:

Synonyms: CaBP8, CABP8_HUMAN, Calcium binding protein 8, Calcium binding protein, Calcium binding protein CABP8, Calcium-binding protein 8, Caln1, Calneuron I, Calneuron-1, Calneuron1.

Background: This gene encodes a protein with high similarity to the calcium-binding proteins of the calmodulin family. The encoded protein contains two EF-hand domains and potential calcium-binding sites. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008].